|
|
DeciZen
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 61 |
Q
V+
PT
|
6,580 Small Cap |
6,045.15 (0.53%) |
26.92 | 4.99 | 14.01 | 17.17 |
|
|
| 62 |
Q
V
PT
|
931 Small Cap |
190.50 (-1.24%) |
30.64 | 2.08 | 8.61 | 14.34 |
|
|
| 63 |
Q
V
PT
|
2,193 Small Cap |
128.80 (-4.20%) |
N/A | N/A | 19.21 | 12.72 |
|
|
| 64 |
Q
V
PT
|
9,570 Small Cap |
1,464 (0.30%) |
50.01 | 5.95 | 21.03 | 54.25 |
|
|
| 65 |
Q
V+
PT
|
15,703 Small Cap |
994.45 (0.87%) |
789.08 | 6.79 | -24.99 | -38.93 |
|
|
| 66 |
Q
V+
PT
|
38,385 Small Cap |
2,418.05 (1.14%) |
56.94 | 9.51 | 15.51 | 9.89 |
|
|
| 67 |
Q
V+
PT
|
1,560 Small Cap |
232.95 (-1.67%) |
36.2 | 6.57 | 11.13 | 39.15 |
|
|
| 68 |
Q
V+
PT
|
45,168 Mid Cap |
1,771.90 (-0.47%) |
39.88 | 5.66 | 8.87 | 4.68 |
|
|
| 69 |
Q
V+
PT
|
4,239 Small Cap |
171.50 (18.77%) |
30.79 | 2.36 | 0.00 | 0.00 |
|
|
| 70 |
Q
V
PT
|
5,466 Small Cap |
962.60 (0.79%) |
65.31 | 6.16 | 25.90 | 14.68 |
|
|
| 71 |
Q
V+
PT
|
3,496 Small Cap |
380 (-0.35%) |
19.04 | 4.72 | 10.30 | 29.46 |
|
|
| 72 |
Q
V+
PT
|
2,178 Small Cap |
240.30 (1.84%) |
N/A | 1.98 | 6.54 | -182.78 |
|
|
| 73 |
Q
V+
PT
|
11,907 Small Cap |
495.35 (0.22%) |
29.68 | 3.79 | 34.59 | 31.10 |
|
|
| 74 |
Q
V+
PT
|
2,713 Small Cap |
217.85 (-0.98%) |
N/A | 2.26 | 4.29 | -1.50 |
|
|
| 75 |
Q
V
PT
|
1,840 Small Cap |
2,201.50 (1.77%) |
35.32 | 4.78 | 6.98 | 0.80 |
|
|
| 76 |
Q
V+
PT
|
9,723 Small Cap |
649.75 (-0.23%) |
666.89 | 6.06 | 13.15 | 0.00 |
|
|
| 77 |
Q
V
PT
|
1,018 Small Cap |
320.95 (0.30%) |
N/A | 3.76 | 109.54 | -201.92 |
|
|
| 78 |
Q
V+
PT
|
4,197 Small Cap |
378.45 (-1.75%) |
89.91 | 14.59 | 12.12 | 15.55 |
|
|
| 79 |
Q
V+
PT
|
1,010 Small Cap |
128.55 (0.31%) |
102.05 | 4.1 | 0.00 | 0.00 |
|
|
| 80 |
Q
V
PT
|
3,761 Small Cap |
374.35 (-0.19%) |
59.56 | 5.66 | 16.69 | 24.75 |
|
|
| 81 |
Q
V+
PT
|
21,172 Small Cap |
861.35 (0.81%) |
52.84 | 4.81 | 5.58 | -0.56 |
|
|
| 82 |
Q
V
PT
|
1,298 Small Cap |
157.80 (-0.25%) |
30.75 | 4.82 | 13.96 | 24.04 |
|
|
| 83 |
Q
V
PT
|
36,284 Small Cap |
1,320 (-2.19%) |
73.12 | 9.02 | 16.83 | 34.86 |
|
|
| 84 |
Q
V+
PT
|
64,072 Mid Cap |
2,282.20 (0.52%) |
47.05 | 6.1 | 4.60 | 14.41 |
|
|
| 85 |
Q
V
PT
|
40,668 Mid Cap |
2,397 (-0.15%) |
39.26 | 17.81 | 5.49 | 17.52 |
|
|
| 86 |
Q
V
PT
|
40,621 Small Cap |
2,513.65 (2.08%) |
31.26 | 3.76 | 9.35 | 7.37 |
|
|
| 87 |
Q
V+
PT
|
73,948 Mid Cap |
981 (0.15%) |
321.04 | 8.01 | 15.55 | -22.45 |
|
|
| 88 |
Q
V
PT
|
2,479 Small Cap |
37.43 (-1.16%) |
N/A | 7.94 | 96.10 | 0.00 |
|
|
| 89 |
Q
V
PT
|
1,163 Small Cap |
374.65 (-5.15%) |
18.08 | 2.75 | 7.46 | 0.93 |
|
|
| 90 |
Q
V
PT
|
7,000 Small Cap |
426.40 (-0.83%) |
24.48 | 2.81 | 9.23 | 1.32 |
|
|
Pharma - Today's Top Gainers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 171.50 | 18.77% | |
| 966.80 | 3.77% | |
| 390.50 | 2.88% | |
| 501.95 | 2.72% | |
| 639.70 | 2.47% |
Pharma - Today's Top Losers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 374.65 | -5.15% | |
| 2,540 | -4.27% | |
| 128.80 | -4.20% | |
| 1,610 | -3.24% | |
| 282.90 | -2.25% |
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | Zydus Lifesciences Ltd. | 1,14,518 Crore |
| 2 | Yatharth Hospital & Trauma Care Services Ltd. | 8,131 Crore |
| 3 | Wockhardt Ltd. | 31,129 Crore |
| 4 | Windlas Biotech Ltd. | 1,773 Crore |
| 5 | Wanbury Ltd. | 993 Crore |
| 6 | Viyash Scientific Ltd. | 12,643 Crore |
| 7 | Vimta Labs Ltd. | 2,525 Crore |
| 8 | Vijaya Diagnostic Centre Ltd. | 13,879 Crore |
| 9 | Unichem Laboratories Ltd. | 3,267 Crore |
| 10 | Torrent Pharmaceuticals Ltd. | 1,63,246 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 26,690 | 57,058 | 36.76 | 11.95 | 25.14 | 35.71 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,853 | 1,63,246 | 75.46 | 19.46 | 39.62 | 29.04 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,318 | 42,118 | 39.88 | 9.31 | 26.95 | 25.35 |
| Lupin Ltd. (M) | Somewhat Good | 2,497 | 1,13,963 | 21.37 | 5.08 | 12.36 | 20.83 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,156 | 1,14,518 | 22.72 | 4.40 | 13.90 | 20.74 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,501 | 82,615 | 97.06 |
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,418 | 38,385 | 46.04 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,853 | 1,63,246 | 43.21 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,589 | 91,709 | 33.87 |
| Gland Pharma Ltd. (S) | Very Good | 2,514 | 40,621 | 31.41 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,418 | 38,385 | 56.94 | 9.51 | 34.49 | 15.51 |
| Mankind Pharma Ltd. (M) | Very Good | 2,532 | 1,04,911 | 51.49 | 6.40 | 32.31 | 14.65 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,318 | 42,118 | 39.88 | 9.31 | 26.95 | 13.54 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,369 | 1,14,246 | 27.23 | 3.03 | 15.19 | 12.09 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,853 | 1,63,246 | 75.46 | 19.46 | 39.62 | 11.80 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. (M) | Very Good | 1,156 | 1,14,518 | 22.72 | 4.40 | 13.90 | 30.57 |
| Sun Pharmaceutical Industries Ltd. (L) | Very Good | 1,916 | 4,59,005 | 39.98 | 5.49 | 22.91 | 23.50 |
| Abbott India Ltd. (M) | Very Good | 26,690 | 57,058 | 36.76 | 11.95 | 25.14 | 18.78 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,369 | 1,14,246 | 27.23 | 3.03 | 15.19 | 15.75 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,282 | 64,072 | 47.05 | 6.10 | 12.50 | 14.41 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: